Serum Direct Bilirubin as a Biomarker for Breast Cancer
Serum DB was identified as a risk factor for breast cancer, demonstrating good diagnostic potential for the disease. These findings suggest that serum DB could serve as a promising serum molecular marker for breast cancer.
Authors
- Yijun Chen (ORCID: https://orcid.org/0000-0002-3209-8730)
- Jinxi Hu
- Xiaoli Zhu (ORCID: https://orcid.org/0000-0002-5472-224X)
- Cai Y (ORCID: https://orcid.org/0000-0003-1039-2741)
Institutions
- Wenzhou Medical University (CN)
Publication Details
- Journal
- Breast Cancer Targets and Therapy
- Published
- 2024-11-01
- DOI
- https://doi.org/10.2147/bctt.s491523
- Citations
- 1
- Primary Topic
- Heme Oxygenase-1 and Carbon Monoxide
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- Science and Technology Program of Zhejiang Province